Menentukan Topik,

Mengumpulkan Bukti, Diseminasi

Hasil dan Rekomendasi

Prof. dr. Mohammad Hakimi, SpOG(K), PhD.

Konsultan Program Studi S2 Kebidanan
Universitas Aisyiyah Yogyakarta

1
technology |tɛkˈnɒlədʒi|
noun

• the application of scientific knowledge

for practical purposes

2
PATH is an international, nonprofit global health organization based in Seattle, with 1,600
employees in more than 70 countries around the world. Its president and CEO is Nikolaj
Gilbert, who is also the Managing Director and CEO of Foundations for Appropriate
Technologies in Health, PATH's Swiss subsidiary.
PATH focuses on six platforms—vaccines, drugs, diagnostics, devices, and system and
service innovations—to develop innovations and implement solutions that save lives and
improve health.
(2022) 3
4
5
 SUSTAINABLE DEVELOPMENT GOAL 3
Ensure healthy lives and promote well-
being for all at all ages

• Achieve the target of less than 70 maternal

deaths per 100,000 live births by 2030.
6
7
8
9
10
11
12
The gap-filling potential for health
• This category focuses on the technology’s potential for
reducing morbidity and mortality and filling existing
“gaps.”
• Technologies that are used earlier in the treatment
continuum (e.g., prevention) generally receive a higher
ranking because of their potential to prevent life-
threatening conditions, reduce unnecessary morbidity and
mortality, and reduce the need for emergency care.
• Other considerations in this category include the strength
of available data and the percentage of cases that could
be better managed with the technology.
13
 Natural history of disease

Onset of Usual time of

symptoms diagnosis
Exposure

Pathologic
changes

Stage of Stage of Stage of Stage of

susceptibility subclinical clinical recovery,
disease disease disability or
death

PRIMARY SECONDARY TERTIARY

PREVENTION PREVENTION PREVENTION
14
 Technology performance
• The criteria in this category concern the clinical
performance, safety, and ease of use of the technology
compared to an existing benchmark, which we
identified by reviewing WHO guidelines.
• We also evaluated usage requirements to highlight
factors that may influence appropriate use in low-
resource settings.
• These requirements include fragile handling, shelf life,
waste disposal, specialized storage needs, electrical
power requirements, infection prevention, and training.

15
 Enabling factors
• We use this category to determine whether an
enabling environment is in place for successful
technology introduction.
• Factors include alignment with international
guidelines, existing support, an acceptability
profile, and existing capabilities.

16
 Market considerations
• We use the criteria in this category to evaluate
the time and investment needed to bring a
technology to market as well as the health
care setting and type of health worker most
likely to use the technology.

17
 Unique considerations
• With this category, we assess other factors that
may significantly affect the introduction and
scaling of the technology, such as system and
bundling requirements and potential disruption
of existing systems.
• “Disruption” is defined as any significant shift in
costs, roles, or risks of any of the stakeholders
that are involved in the acquisition,
distribution, or deployment of technologies.
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Health technologies for women

32
33
34
35
36
37
38
 Uterine Balloon Tamponade
• “The tamponade… could be particularly
effective in reducing the maternal mortality
rates of low-resource countries, as it can be
performed in small centers with minimal
facilities. WHO considers that this intervention
can be highly effective; it should be rigorously
evaluated as a priority.”

World Health Organization Consulting Group, 2008.

39
40
41
 Non-pneumatic Antishock Garment
• “In our research, women who appeared
clinically dead, with no blood pressure and no
palpable pulse, were resuscitated and kept
alive for up to two days [using the NASG] while
waiting for blood transfusions.”

Suellen Miller, CNM, PhD, International Maternal Health

Expert and Director of the Safe Motherhood Programs of
the University of California, San Francisco Women’s Global
Health Imperative.
42
43
 Uniject [with oxytocin]
• “Uniject [with oxytocin] was well
tolerated and offers an alternative for
oxytocin administration.”

Strand RT, et al. Postpartum hemorrhage: A

prospective, comparative study in Angola using a
new disposable device for oxytocin administration.
Acta Obstetricia et Gynecologica Scandinavica.
2005;84:260–265.
44
45